148 related articles for article (PubMed ID: 1997044)
1. Disposition of morphine-6-glucuronide and morphine in healthy volunteers.
Hanna MH; Peat SJ; Knibb AA; Fung C
Br J Anaesth; 1991 Jan; 66(1):103-7. PubMed ID: 1997044
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine.
Stuart-Harris R; Joel SP; McDonald P; Currow D; Slevin ML
Br J Clin Pharmacol; 2000 Mar; 49(3):207-14. PubMed ID: 10718775
[TBL] [Abstract][Full Text] [Related]
3. Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine.
Hanna MH; Peat SJ; Woodham M; Knibb A; Fung C
Br J Anaesth; 1990 May; 64(5):547-50. PubMed ID: 2354092
[TBL] [Abstract][Full Text] [Related]
4. Morphine, morphine-6-glucuronide and morphine-3-glucuronide pharmacokinetics in newborn infants receiving diamorphine infusions.
Barrett DA; Barker DP; Rutter N; Pawula M; Shaw PN
Br J Clin Pharmacol; 1996 Jun; 41(6):531-7. PubMed ID: 8799518
[TBL] [Abstract][Full Text] [Related]
5. The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide.
Penson RT; Joel SP; Roberts M; Gloyne A; Beckwith S; Slevin ML
Br J Clin Pharmacol; 2002 Apr; 53(4):347-54. PubMed ID: 11966664
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences.
Romberg R; Olofsen E; Sarton E; den Hartigh J; Taschner PE; Dahan A
Anesthesiology; 2004 Jan; 100(1):120-33. PubMed ID: 14695733
[TBL] [Abstract][Full Text] [Related]
7. Naloxone reversal of morphine- and morphine-6-glucuronide-induced respiratory depression in healthy volunteers: a mechanism-based pharmacokinetic-pharmacodynamic modeling study.
Olofsen E; van Dorp E; Teppema L; Aarts L; Smith TW; Dahan A; Sarton E
Anesthesiology; 2010 Jun; 112(6):1417-27. PubMed ID: 20461002
[TBL] [Abstract][Full Text] [Related]
8. Randomized placebo-controlled trial of the activity of the morphine glucuronides.
Penson RT; Joel SP; Bakhshi K; Clark SJ; Langford RM; Slevin ML
Clin Pharmacol Ther; 2000 Dec; 68(6):667-76. PubMed ID: 11180027
[TBL] [Abstract][Full Text] [Related]
9. The transfer half-life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers.
Lötsch J; Skarke C; Schmidt H; Grösch S; Geisslinger G
Anesthesiology; 2001 Dec; 95(6):1329-38. PubMed ID: 11748388
[TBL] [Abstract][Full Text] [Related]
10. Morphine-6-glucuronide disposition in renal impairment.
Hanna MH; D'Costa F; Peat SJ; Fung C; Venkat N; Zilkha TR; Davies S
Br J Anaesth; 1993 May; 70(5):511-4. PubMed ID: 8318321
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of Morphine and Morphine-6-Glucuronide During Postoperative Pain Therapy in Cardiac Surgery Patients.
Ihmsen H; Schüttler J; Jeleazcov C
Eur J Drug Metab Pharmacokinet; 2021 Mar; 46(2):249-263. PubMed ID: 33547559
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of morphine-6-glucuronide following oral administration in healthy volunteers.
Villesen HH; Kristensen K; Hansen SH; Jensen NH; Skram U; Christrup LL
Eur J Clin Pharmacol; 2007 Aug; 63(8):761-7. PubMed ID: 17541571
[TBL] [Abstract][Full Text] [Related]
13. Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide.
de Hoogd S; Välitalo PAJ; Dahan A; van Kralingen S; Coughtrie MMW; van Dongen EPA; van Ramshorst B; Knibbe CAJ
Clin Pharmacokinet; 2017 Dec; 56(12):1577-1587. PubMed ID: 28510797
[TBL] [Abstract][Full Text] [Related]
14. Morphine-6-glucuronide: morphine's successor for postoperative pain relief?
van Dorp EL; Romberg R; Sarton E; Bovill JG; Dahan A
Anesth Analg; 2006 Jun; 102(6):1789-97. PubMed ID: 16717327
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic modeling to predict morphine and morphine-6-glucuronide plasma concentrations in healthy young volunteers.
Lötsch J; Skarke C; Schmidt H; Liefhold J; Geisslinger G
Clin Pharmacol Ther; 2002 Aug; 72(2):151-62. PubMed ID: 12189362
[TBL] [Abstract][Full Text] [Related]
16. Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers.
Murthy BR; Pollack GM; Brouwer KL
J Clin Pharmacol; 2002 May; 42(5):569-76. PubMed ID: 12017351
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries.
Perreault S; Choinière M; du Souich PB; Bellavance F; Beauregard G
Ann Pharmacother; 2001 Dec; 35(12):1588-92. PubMed ID: 11793627
[TBL] [Abstract][Full Text] [Related]
18. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children.
Bouwmeester NJ; Anderson BJ; Tibboel D; Holford NH
Br J Anaesth; 2004 Feb; 92(2):208-17. PubMed ID: 14722170
[TBL] [Abstract][Full Text] [Related]
19. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations.
Hasselström J; Säwe J
Clin Pharmacokinet; 1993 Apr; 24(4):344-54. PubMed ID: 8491060
[TBL] [Abstract][Full Text] [Related]
20. Different distribution of morphine and morphine-6 beta-glucuronide after intracerebroventricular injection in rats.
Okura T; Saito M; Nakanishi M; Komiyama N; Fujii A; Yamada S; Kimura R
Br J Pharmacol; 2003 Sep; 140(1):211-7. PubMed ID: 12967951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
